Your browser doesn't support javascript.
loading
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
Stormo, Adrienne E D; Shavarebi, Farbod; FitzGibbon, Molly; Earley, Elizabeth M; Ahrendt, Hannah; Lum, Lotus S; Verschueren, Erik; Swaney, Danielle L; Skibinski, Gaia; Ravisankar, Abinaya; van Haren, Jeffrey; Davis, Emily J; Johnson, Jeffrey R; Von Dollen, John; Balen, Carson; Porath, Jacob; Crosio, Claudia; Mirescu, Christian; Iaccarino, Ciro; Dauer, William T; Nichols, R Jeremy; Wittmann, Torsten; Cox, Timothy C; Finkbeiner, Steve; Krogan, Nevan J; Oakes, Scott A; Hiniker, Annie.
Afiliação
  • Stormo AED; Departments of Pathology, University of California San Francisco, San Francisco, CA.
  • Shavarebi F; Department of Pathology, University of California San Diego, San Diego, CA.
  • FitzGibbon M; Department of Pathology, University of California San Diego, San Diego, CA.
  • Earley EM; Departments of Pathology, University of California San Francisco, San Francisco, CA.
  • Ahrendt H; Department of Pathology, University of California San Diego, San Diego, CA.
  • Lum LS; Departments of Pathology, University of California San Francisco, San Francisco, CA.
  • Verschueren E; Departments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA.
  • Swaney DL; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA.
  • Skibinski G; Departments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA.
  • Ravisankar A; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA.
  • van Haren J; Taube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes, San Francisco, CA.
  • Davis EJ; Center for Systems and Therapeutics, J. David Gladstone Institutes, San Francisco, CA.
  • Johnson JR; Taube/Koret Center for Neurodegenerative Disease Research, J. David Gladstone Institutes, San Francisco, CA.
  • Von Dollen J; Center for Systems and Therapeutics, J. David Gladstone Institutes, San Francisco, CA.
  • Balen C; Departments of Cell and Tissue Biology, University of California San Francisco, San Francisco, CA.
  • Porath J; Department of Cell Biology, Erasmus MC, Rotterdam, The Netherlands.
  • Crosio C; Departments of Pathology, University of California San Francisco, San Francisco, CA.
  • Mirescu C; Departments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA.
  • Iaccarino C; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA.
  • Dauer WT; Departments of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA.
  • Nichols RJ; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, CA.
  • Wittmann T; Department of Pathology, University of California San Diego, San Diego, CA.
  • Cox TC; Department of Pathology, University of California San Diego, San Diego, CA.
  • Finkbeiner S; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Krogan NJ; Neuroscience, Merck & Co. Inc., Boston, MA.
  • Oakes SA; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Hiniker A; Departments of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX.
J Cell Biol ; 221(4)2022 04 04.
Article em En | MEDLINE | ID: mdl-35266954

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Serina-Treonina Quinases / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina / Proteínas com Motivo Tripartido Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas Serina-Treonina Quinases / Serina-Treonina Proteína Quinase-2 com Repetições Ricas em Leucina / Proteínas com Motivo Tripartido Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article